Loading patent…
AssigneeBiobalance Co., Ltd.
InventorsMark Olshenitsky, Genadi Buchman
Estimating the term…
The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.
A biologically homogeneous and pure culture of Escherichia coli strain BU-230-98, ATCC Deposit No. 202226 and DSM 12799.
A probiotic composition comprising, as an active ingredient, viable biologically homogeneous and pure Escherichia coli strain BU-230-98, ATCC Deposit No. 202226 and DSM 12799, and a formulation comprising at least one volatile fraction (VF) of a plant extract, wherein said plant extract is obtained by water extraction and wherein said volatile fraction (VF) of a plant extract is obtained by steam distillation of said plant extract under a pressure lower than atmospheric pressure and at a bath temperature not exceeding 38° C. for maintaining viability of said Escherichia coli strain.
Dependencies are inferred from the claim text.